193 related articles for article (PubMed ID: 30291346)
21. Dedifferentiated chondrosarcoma of bone with prominent rhabdoid component.
Stemm M; Beck C; Mannem R; Neilson J; Klein MJ
Ann Diagn Pathol; 2017 Jun; 28():7-11. PubMed ID: 28648942
[TBL] [Abstract][Full Text] [Related]
22. Morphological typing of chondrosarcoma: a study of 94 cases.
Welkerling H; Dreyer T; Delling G
Virchows Arch A Pathol Anat Histopathol; 1991; 418(5):419-25. PubMed ID: 2035255
[TBL] [Abstract][Full Text] [Related]
23. Dedifferentiated chondrosarcomas arising in preexisting osteochondromas.
Staals EL; Bacchini P; Mercuri M; Bertoni F
J Bone Joint Surg Am; 2007 May; 89(5):987-93. PubMed ID: 17473135
[TBL] [Abstract][Full Text] [Related]
24. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
[TBL] [Abstract][Full Text] [Related]
25. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of a dedifferentiated chondrosarcoma of the pelvis by fine needle aspiration. A case report.
Estrada-Villaseñor E; Rico-Martínez G; Linares-Gonzalez LM
Acta Cytol; 2010; 54(2):217-20. PubMed ID: 20391984
[TBL] [Abstract][Full Text] [Related]
27. Dedifferentiated peripheral chondrosarcomas. A report of seven cases.
Bertoni F; Present D; Bacchini P; Picci P; Pignatti G; Gherlinzoni F; Campanacci M
Cancer; 1989 May; 63(10):2054-9. PubMed ID: 2702574
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
29. Genomic Profiling of Low-grade Intramedullary Cartilage Tumors Can Distinguish Enchondroma From Chondrosarcoma.
Joseph NM; McGill KC; Horvai AE
Am J Surg Pathol; 2021 Jun; 45(6):812-819. PubMed ID: 33239505
[TBL] [Abstract][Full Text] [Related]
30. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.
Schaefer IM; Fletcher CD; Hornick JL
Mod Pathol; 2016 Jan; 29(1):4-13. PubMed ID: 26585554
[TBL] [Abstract][Full Text] [Related]
31. Molecular distinction of chondrosarcoma from chondroblastic osteosarcoma through IDH1/2 mutations.
Kerr DA; Lopez HU; Deshpande V; Hornicek FJ; Duan Z; Zhang Y; Rosenberg AE; Borger DR; Nielsen GP
Am J Surg Pathol; 2013 Jun; 37(6):787-95. PubMed ID: 23598960
[TBL] [Abstract][Full Text] [Related]
32. H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
Lyskjaer I; Lindsay D; Tirabosco R; Steele CD; Lombard P; Strobl AC; Rocha AM; Davies C; Ye H; Bekers E; Ingruber J; Lechner M; Amary F; Pillay N; Flanagan AM
J Pathol; 2020 Oct; 252(2):151-164. PubMed ID: 32666581
[TBL] [Abstract][Full Text] [Related]
33. Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone.
van Oosterwijk JG; de Jong D; van Ruler MA; Hogendoorn PC; Dijkstra PD; van Rijswijk CS; Machado I; Llombart-Bosch A; Szuhai K; Bovée JV
BMC Cancer; 2012 Aug; 12():375. PubMed ID: 22928481
[TBL] [Abstract][Full Text] [Related]
34. Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.
Meijer D; de Jong D; Pansuriya TC; van den Akker BE; Picci P; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2012 Oct; 51(10):899-909. PubMed ID: 22674453
[TBL] [Abstract][Full Text] [Related]
35. Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Cancer Res Clin Oncol; 1999 Oct; 125(10):541-8. PubMed ID: 10473866
[TBL] [Abstract][Full Text] [Related]
36. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.
Mito JK; Qian X; Doyle LA; Hornick JL; Jo VY
Am J Clin Pathol; 2017 Aug; 148(2):179-189. PubMed ID: 28898989
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
[TBL] [Abstract][Full Text] [Related]
38. Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report.
Huang J; Jiang Z; Yang Q; Zhang H
Int J Surg Pathol; 2013 Feb; 21(1):48-53. PubMed ID: 22736299
[TBL] [Abstract][Full Text] [Related]
39. Dedifferentiated peripheral chondrosarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of four cases.
Franchi A; Baroni G; Sardi I; Giunti L; Capanna R; Campanacci D
Virchows Arch; 2012 Mar; 460(3):335-42. PubMed ID: 22350005
[TBL] [Abstract][Full Text] [Related]
40. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
